This finding indicates the existence of an unknown factor that could work independently of and/or in cooperation with IKZF1 to mediate oncogenic transcription in MM cells and could promote IMiD resistance by maintaining IRF4 transcription after IKZF1 degradation. This evidence concerns the gene IRF4 and Miyoshi myopathy.